313 related articles for article (PubMed ID: 33684161)
21. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
22. LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1.
Pan C; Wang Q; Wang H; Deng X; Chen L; Li Z
Carcinogenesis; 2024 May; 45(5):311-323. PubMed ID: 38153696
[TBL] [Abstract][Full Text] [Related]
23. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
24. Microarray profiling of differentially expressed lncRNAs and mRNAs in lung adenocarcinomas and bioinformatics analysis.
He F; Huang L; Xu Q; Xiong W; Liu S; Yang H; Lu W; Xiao R; Hu Z; Cai L
Cancer Med; 2020 Oct; 9(20):7717-7728. PubMed ID: 32869486
[TBL] [Abstract][Full Text] [Related]
25. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
Zhu Y; Bo H; Chen Z; Li J; He D; Xiao M; Xiang L; Jin L; Zhou J; Gong L; Zhou Y; Zhou M; Xiong W; Xing X; Li R; Cao K
Aging (Albany NY); 2020 Nov; 12(21):21904-21922. PubMed ID: 33147570
[TBL] [Abstract][Full Text] [Related]
26. Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung.
Miao H; Chen D; Li R; Hu J; Chen Y; Xu C; Wen Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33324975
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.
Fan F; Ping Y; Yang L; Duan X; Resegofetse Maimela N; Li B; Li X; Chen J; Zhang K; Wang L; Liu S; Zhao X; Wang H; Zhang Y
J Cell Mol Med; 2020 Oct; 24(20):11680-11690. PubMed ID: 32860342
[TBL] [Abstract][Full Text] [Related]
28. Construction and investigation of a combined hypoxia and stemness index lncRNA-associated ceRNA regulatory network in lung adenocarcinoma.
Guo L; Li H; Li W; Tang J
BMC Med Genomics; 2020 Nov; 13(1):166. PubMed ID: 33148251
[TBL] [Abstract][Full Text] [Related]
29. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
[TBL] [Abstract][Full Text] [Related]
30. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
31. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
[TBL] [Abstract][Full Text] [Related]
32. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
Han S; Cao D; Sha J; Zhu X; Chen D
Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
34. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
Liu B; Chen Y; Yang J
Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
[TBL] [Abstract][Full Text] [Related]
35. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
36. [Expression and prognosis effect of methylation-regulated SLIT3 and SPARCL1 genes in smoking-related lung adenocarcinoma].
Wang J; Yu XF; Ouyang N; Zhao SY; Guan XF; Yao HP; Chen R; Chen T; Li JX
Zhonghua Yi Xue Za Zhi; 2019 May; 99(20):1553-1557. PubMed ID: 31154721
[No Abstract] [Full Text] [Related]
37. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
39. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Chen D; Luo L; Liang C
PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide analyses of long noncoding RNA expression profiles in lung adenocarcinoma.
Peng Z; Wang J; Shan B; Yuan F; Li B; Dong Y; Peng W; Shi W; Cheng Y; Gao Y; Zhang C; Duan C
Sci Rep; 2017 Nov; 7(1):15331. PubMed ID: 29127420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]